Free Trial

Equifax (EFX) Stock Forecast & Price Target

Equifax logo
$264.48 +3.87 (+1.48%)
Closing price 05/2/2025 03:59 PM Eastern
Extended Trading
$269.40 +4.92 (+1.86%)
As of 05/2/2025 04:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Equifax - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
5
Buy
14

Based on 19 Wall Street analysts who have issued ratings for Equifax in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 5 have given a hold rating, 13 have given a buy rating, and 1 has given a strong buy rating for EFX.

Consensus Price Target

$292.00
10.41% Upside
According to the 19 analysts' twelve-month price targets for Equifax, the average price target is $292.00. The highest price target for EFX is $333.00, while the lowest price target for EFX is $260.00. The average price target represents a forecasted upside of 10.41% from the current price of $264.48.
Get the Latest News and Ratings for EFX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Equifax and its competitors.

Sign Up

EFX Analyst Ratings Over Time

TypeCurrent Forecast
5/4/24 to 5/4/25
1 Month Ago
4/4/24 to 4/4/25
3 Months Ago
2/4/24 to 2/3/25
1 Year Ago
5/5/23 to 5/4/24
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
13 Buy rating(s)
13 Buy rating(s)
15 Buy rating(s)
14 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
2 Hold rating(s)
3 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$292.00$294.50$310.41$270.19
Forecasted Upside10.41% Upside40.04% Upside16.03% Upside19.00% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

EFX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Equifax Stock vs. The Competition

TypeEquifaxBusiness Services CompaniesS&P 500
Consensus Rating Score
2.79
2.72
2.54
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside10.41% Upside451.03% Upside17.54% Upside
News Sentiment Rating
Positive News

See Recent EFX News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/23/2025Royal Bank of Canada
4 of 5 stars
A. Sabadra
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$300.00 ➝ $300.00+20.12%
4/23/2025Needham & Company LLC
2 of 5 stars
Kyle Peterson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$295.00 ➝ $295.00+20.05%
4/14/2025Wells Fargo & Company
3 of 5 stars
Jason Haas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$313.00 ➝ $284.00+27.16%
4/10/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$280.00+28.80%
4/4/2025Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Manav Patnaik
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Equal Weight$325.00 ➝ $260.00+12.33%
3/14/2025BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Grobler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral$265.00+11.75%
2/18/2025Gordon Haskett
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Grom
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
2/11/2025Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Eade
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
2/7/2025Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Owen Lau
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$286.00 ➝ $279.00+13.28%
2/7/2025Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Shlomo Rosenbaum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$284.00 ➝ $281.00+13.95%
2/7/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Mcveigh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$335.00 ➝ $310.00+25.71%
2/7/2025William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform
1/28/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Toni Kaplan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$320.00 ➝ $316.00+14.67%
1/15/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Surinder Thind
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$340.00 ➝ $300.00+13.77%
12/12/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Wurtzel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Peer Perform
11/19/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight ➝ Overweight$304.00 ➝ $283.00+16.93%
10/18/2024Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$290.00 ➝ $333.00+18.01%
8/20/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$277.00 ➝ $307.00+4.23%
7/24/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$263.00 ➝ $304.00+15.32%
2/13/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeIn-Line ➝ Outperform$210.00 ➝ $310.00+21.21%
2/9/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$270.00 ➝ $285.00+14.38%
1/11/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$272.00+11.10%
12/8/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$218.00 ➝ $267.00+19.05%
7/21/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$235.00 ➝ $250.00+15.54%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 02:33 AM ET.


Should I Buy Equifax Stock? EFX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, April 29, 2025. Please send any questions or comments about these Equifax pros and cons to contact@marketbeat.com.

Equifax
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Equifax Inc.:

  • The current stock price is around $254, which may present a buying opportunity for investors looking for value in the credit services sector.
  • Equifax Inc. recently reported earnings that exceeded analysts' expectations, indicating strong financial performance and potential for future growth.
  • The company has a solid market capitalization of approximately $31.55 billion, reflecting its stability and presence in the industry.
  • Equifax Inc. has a history of increasing dividends, with a recent boost to $0.50 per share, which can attract income-focused investors.
  • Analysts have a consensus rating of "Moderate Buy" for Equifax Inc., suggesting positive sentiment and potential for stock appreciation.

Equifax
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Equifax Inc. for these reasons:

  • The stock has a high price-to-earnings (P/E) ratio of around 52.59, which may indicate that it is overvalued compared to its earnings.
  • Equifax Inc. has experienced recent downgrades from several analysts, which could signal concerns about its future performance.
  • The company has a relatively low current ratio of 0.75, suggesting potential liquidity issues that could affect its ability to meet short-term obligations.
  • With a beta of 1.65, Equifax Inc. is more volatile than the market, which could lead to larger price swings and increased risk for investors.
  • Recent changes in analyst price targets have shown a downward trend, indicating a cautious outlook on the stock's future price movements.

EFX Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Equifax is $292.00, with a high forecast of $333.00 and a low forecast of $260.00.

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Equifax in the last year. There are currently 5 hold ratings, 13 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" EFX shares.

According to analysts, Equifax's stock has a predicted upside of 10.41% based on their 12-month stock forecasts.

Over the previous 90 days, Equifax's stock had 2 upgrades and 2 downgrades by analysts.

Analysts like Equifax more than other "business services" companies. The consensus rating score for Equifax is 2.79 while the average consensus rating score for "business services" companies is 2.72. Learn more on how EFX compares to other companies.


This page (NYSE:EFX) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners